Literature DB >> 11278132

The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia.

R A Emsley1, D J Niehaus, N I Mbanga, P P Oosthuizen, D J Stein, J S Maritz, S N Pimstone, M R Hayden, C Laurent, J F Deleuze, J Mallet.   

Abstract

Most studies investigating the symptom dimensions of schizophrenia utilising the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS) favour a three factor model. This study sought to investigate the factor structure of both the global and individual items of the SANS and SAPS in a large sample of South African Xhosa patients with schizophrenia. A total of 422 subjects participated. Both principal components and factor analytical procedures were applied. For the global items, a two-factor solution representing positive and negative symptoms accounted for 59.9% of the variance. Alternatively, the three-dimensional model of negative, psychotic and disorganisation factors was supported by a five-factor solution if the more heterogeneous items of attention and alogia were ignored. Analysis of the individual items yielded a five-factor solution with the negative symptoms splitting into diminished expression and disordered relating, and the positive symptoms separating into factors for psychosis, thought disorder and bizarre behaviour. Our findings are very similar to those from other parts of the world, providing evidence that the factor structure for the symptoms of schizophrenia is relatively resistant to cultural influences. This is particularly true for negative symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11278132     DOI: 10.1016/s0920-9964(00)00010-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

Review 1.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 2.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

3.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  The diagnostic concept of schizophrenia: its history, evolution, and future prospects.

Authors:  Assen Jablensky
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

5.  Morphological features in a Xhosa schizophrenia population.

Authors:  Liezl Koen; Dana J H Niehaus; Greetje De Jong; Jacqueline E Muller; Esme Jordaan
Journal:  BMC Psychiatry       Date:  2006-10-27       Impact factor: 3.630

Review 6.  Neurological Soft Signs in Schizophrenia: An Update on the State- versus Trait-Perspective.

Authors:  Silke Bachmann; Johannes Schröder
Journal:  Front Psychiatry       Date:  2018-01-08       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.